Source link : https://newshealth.biz/health-news/trial-results-could-shuffle-order-of-btk-inhibitors-for-cll-sll/
(MedPage Today) — ORLANDO — In a phase III trial with potential practice-changing implications, the non-covalent Bruton’s tyrosine kinase (BTK) inhibitor pirtobrutinib (Jaypirca) induced a higher response rate in chronic lymphocytic leukemia… Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118892 Author : Publish date : 2025-12-08 19:40:00 Copyright for syndicated content belongs to the linked Source.
The post Trial Results Could Shuffle Order of BTK Inhibitors for CLL/SLL first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-08 19:40:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8